NVDA
NVIDIA
-- 117.520 TSLA
Tesla
-- 235.860 INTC
Intel
-- 24.120 PLTR
Palantir
-- 86.100 AAPL
Apple
-- 215.240 
🟤 Watchlist, FEBRUARY 6,2025,Thursday. NFA - DrJag8
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AWAY and I won’t think twice blocking you. I shun uncouth and toxic people in my life.
AGAIN, NEVER OPEN A POSITION WITHOUT ANALYZING CHART, INDICATORS, ORDER BOOK, SHORTS AVAILABILITY
To my silent stalkers: You are welcome 🤣
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FEBRUARY 5 NEWS
$Aurora Cannabis (ACB.US)$ PR 2/5 ER: Record net income of $31.2M, up 282% YoY; Global medical cannabis revenue increased 51% to $68.1M;
Adjusted EBITDA grew 316% to $23.1M;
Generated positive free cash flow of $27.4M Strong medical cannabis gross margins of 74% International revenue growth of 112%.
$BigBear.ai Holdings (BBAI.US)$ PR 2/5 secured a Department of Defense (DoD) contract to advance its Virtual Anticipation Network (VANE) prototype. The VANE system aggregates and analyzes data to predict adversarial activity in complex situations. SI 20.56%. COH $54.4M good for 21 months
$Creative Medical Technology (CELZ.US)$ PR 2/5 announced an expanded agreement with Greenstone Biosciences Inc. to leverage Artificial Intelligence (AI) in further developing its human induced pluripotent stem cell (iPSC) platform for diabetes treatment. COH $6.4M good for 17 months
$Datasea (DTSS.US)$ PR 2/5 Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year; Gross profit increase of 310% YoY. China low float stock.
$Helix Energy Solutions (HLX.US)$ PR AH 2/5 Awarded Significant Trenching Services Contract, one of the largest trenching awards of the company. Helix is a global leader in subsea robotics and trenching. No dilution risk
$EyePoint Pharmaceuticals (EYPT.US)$ PR 2/5 Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints. Beaten by shorts today. SI 21.78%. COH $348M.
$Inspira Technologies Oxy (IINN.US)$ PR 2/5 announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology. This enhancement enables continuous monitoring of tissue oxygenation and early hypoxia detection without requiring intermittent blood draws. Low float. SI 16.54%. COH $4.5M good for 5.6 months
$Lucky Strike Entertainment (LUCK.US)$ PR 2/5 ER Net income improved significantly to $28.3M from prior year loss of $63.5M. Maintained positive guidance for FY2025 with expected revenue of $1.23-1.28B. Low float. SI 56.61%. 0 shares LTB.
$Rani Therapeutics (RANI.US)$ PR AH 2/5 Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC which achieved comparable bioavailability (107%) and pharmacokinetics to subcutaneous administration. Up AH. COH $26.9M good for 9 months.
$VCI Global (VCIG.US)$ PR 2/5 announced the development of a next-generation AI aggregator platform designed to streamline AI integration, the platform will provide seamless access to major AI models, such as DeepSeek, OpenAI's ChatGPT, Anthropic's Claude, Google Gemini, Mistral AI, and other emerging AI technologies. Relatively low float.
$Beyond Air (XAIR.US)$ PR 2/5 Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement. COH $11.8M good for 3 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
PREVIOUS DAYS’ NEWS
$Cognition Therapeutics (CGTX.US)$ PR 1/30 Positive Phase 2 Study of Zervimesine in Dementia with Lewy Bodies (DLB).
$Cumberland Pharmaceuticals (CPIX.US)$ PR 2/4 Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease. It’s the first successful Phase 2 study specifically targeting the cardiac complications of their condition. Likely may continue tomorrow. COH $16.3M good for 58 months
$CervoMed (CRVO.US)$ PR 1/31 The Phase 2b RewinD-LB trial found no significant differences between neflamapimod 40mg (TID) and placebo for Dementia with Lewy Bodies (DLB), but a 4Q 2024 study in healthy volunteers showed the new capsules achieved targeted plasma concentrations. Low float. SI 27.45%.
$Genfit (GNFT.US)$ Announces €185 million Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan. COH $72M good for 10 months
$Icon Energy (ICON.US)$ PR 1/31 Buy rating to $1.25. 3 13Gs filed: (1)Jan 30 2 6.9%; (2)Jan 27 9.99%. COH $500K. Low float.
$Knightscope (KSCP.US)$ Achieves Full Federal Risk and Authorization Management Program (FedRAMP®) Authorization, Unlocking Federal Growth.
$Comstock Inc (LODE.US)$ PR 2/4 Approved for $152 Million Allocation for Oklahoma Qualified Private Activity Bonds
$MAIA Biotechnology (MAIA.US)$ PR 2/4 Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer. Showed median overall survival of 16.9 months compared to 56 months in similar setting.
$Nexalin Technology (NXL.US)$ PR 2/3 Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study. Low float. COH $3.4M good for 10.7 months
$Safety Shot (SHOT.US)$ PR 2/3 announced the termination of its at-the-market (ATM) equity offering program, citing strong financial position and positive outlook.
$Safe Pro Group (SPAI.US)$ PR 1/30 Enters Multi-Year Agreement for its Patented Drone AI Demining Platform with Ukraine's Leading Grain Export and Agricultural Organization. COH $900K good for 2.8 months
$Unusual Machines (UMAC.US)$ PR 2/3 Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem. Low float. COH $3M good for 9.9 months
$Valneva (VALN.US)$ PR 1/30 Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million - Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. No dilution risk.
$Vanda Pharmaceuticals (VNDA.US)$ PR 2/3 Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab for Generalized Pustular Psoriasis. COH $369.7M
$Wearable Devices (WLDS.US)$ PR 2/3 announced the development of Large MUAP Models (LMM), a groundbreaking advancement in AI-powered neural gesture control technology. LMMs aim to decode Motor Unit Action Potentials (MUAPs), the body's muscle communication signals, to enable personalized and intuitive device interactions. COH $6.4M good for 10 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE MOMENTUM PLAY
$Digital Turbine (APPS.US)$
$Blue Hat Interactive Entertainment Technology (BHAT.US)$
$COMPASS Pathways (CMPS.US)$
$DHI Group (DHX.US)$
$Huachen AI Parking Management Technology (HCAI.US)$
$Invivyd (IVVD.US)$
$Kirkland's (KIRK.US)$
$Lakeside Holding (LSH.US)$
$MGO Global (MGOL.US)$
$PicoCELA (PCLA.US)$
$Quantum BioPharma (QNTM.US)$
$Transcode Therapeutics (RNAZ.US)$
$SharpLink Gaming (SBET.US)$
$Universe Pharmaceuticals (UPC.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FORM 4s, 13Gs, 13Ds
$AIM ImmunoTech (AIM.US)$ 1/21 Form 4 Code P Insider buy. COH $2.6M good for 2.1 months
$Ardelyx (ARDX.US)$ 1/22 Form 4 insider buy
$Assembly Biosciences (ASMB.US)$ 12/31 Form 4 insider buying. Low float
$Chijet Motor (CJET.US)$ 1/21 13G 8.72%.
$PMGC Holdings (ELAB.US)$ 1/31 13G 9.6%. Low float.
$KALA BIO (KALA.US)$ 12/31 Form 4 huge insider buying. Low float.
$NAYA Biosciences (NAYA.US)$ 1/16 16 13Gs 9.99% and 6.9%. Low float.
$Outlook Therapeutics (OTLK.US)$ 1/22 13D/A 38.6% ownership up from 25%
$SuperCom (SPCB.US)$ 1/31 13G 7.8%. Low float.
$SaverOne 2014 (SVRE.US)$ 2/5 13G 4.99%.
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE POST RS SPIKE
$Eyenovia (EYEN.US)$
$Bionano Genomics (BNGO.US)$
$Kaixin Holdings (KXIN.US)$
$Wheeler Real Estate Investment Trust (WHLR.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
STOCK EDUCATION
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AWAY and I won’t think twice blocking you. I shun uncouth and toxic people in my life.
AGAIN, NEVER OPEN A POSITION WITHOUT ANALYZING CHART, INDICATORS, ORDER BOOK, SHORTS AVAILABILITY
To my silent stalkers: You are welcome 🤣
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FEBRUARY 5 NEWS
$Aurora Cannabis (ACB.US)$ PR 2/5 ER: Record net income of $31.2M, up 282% YoY; Global medical cannabis revenue increased 51% to $68.1M;
Adjusted EBITDA grew 316% to $23.1M;
Generated positive free cash flow of $27.4M Strong medical cannabis gross margins of 74% International revenue growth of 112%.
$BigBear.ai Holdings (BBAI.US)$ PR 2/5 secured a Department of Defense (DoD) contract to advance its Virtual Anticipation Network (VANE) prototype. The VANE system aggregates and analyzes data to predict adversarial activity in complex situations. SI 20.56%. COH $54.4M good for 21 months
$Creative Medical Technology (CELZ.US)$ PR 2/5 announced an expanded agreement with Greenstone Biosciences Inc. to leverage Artificial Intelligence (AI) in further developing its human induced pluripotent stem cell (iPSC) platform for diabetes treatment. COH $6.4M good for 17 months
$Datasea (DTSS.US)$ PR 2/5 Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year; Gross profit increase of 310% YoY. China low float stock.
$Helix Energy Solutions (HLX.US)$ PR AH 2/5 Awarded Significant Trenching Services Contract, one of the largest trenching awards of the company. Helix is a global leader in subsea robotics and trenching. No dilution risk
$EyePoint Pharmaceuticals (EYPT.US)$ PR 2/5 Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints. Beaten by shorts today. SI 21.78%. COH $348M.
$Inspira Technologies Oxy (IINN.US)$ PR 2/5 announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology. This enhancement enables continuous monitoring of tissue oxygenation and early hypoxia detection without requiring intermittent blood draws. Low float. SI 16.54%. COH $4.5M good for 5.6 months
$Lucky Strike Entertainment (LUCK.US)$ PR 2/5 ER Net income improved significantly to $28.3M from prior year loss of $63.5M. Maintained positive guidance for FY2025 with expected revenue of $1.23-1.28B. Low float. SI 56.61%. 0 shares LTB.
$Rani Therapeutics (RANI.US)$ PR AH 2/5 Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC which achieved comparable bioavailability (107%) and pharmacokinetics to subcutaneous administration. Up AH. COH $26.9M good for 9 months.
$VCI Global (VCIG.US)$ PR 2/5 announced the development of a next-generation AI aggregator platform designed to streamline AI integration, the platform will provide seamless access to major AI models, such as DeepSeek, OpenAI's ChatGPT, Anthropic's Claude, Google Gemini, Mistral AI, and other emerging AI technologies. Relatively low float.
$Beyond Air (XAIR.US)$ PR 2/5 Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement. COH $11.8M good for 3 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
PREVIOUS DAYS’ NEWS
$Cognition Therapeutics (CGTX.US)$ PR 1/30 Positive Phase 2 Study of Zervimesine in Dementia with Lewy Bodies (DLB).
$Cumberland Pharmaceuticals (CPIX.US)$ PR 2/4 Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease. It’s the first successful Phase 2 study specifically targeting the cardiac complications of their condition. Likely may continue tomorrow. COH $16.3M good for 58 months
$CervoMed (CRVO.US)$ PR 1/31 The Phase 2b RewinD-LB trial found no significant differences between neflamapimod 40mg (TID) and placebo for Dementia with Lewy Bodies (DLB), but a 4Q 2024 study in healthy volunteers showed the new capsules achieved targeted plasma concentrations. Low float. SI 27.45%.
$Genfit (GNFT.US)$ Announces €185 million Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan. COH $72M good for 10 months
$Icon Energy (ICON.US)$ PR 1/31 Buy rating to $1.25. 3 13Gs filed: (1)Jan 30 2 6.9%; (2)Jan 27 9.99%. COH $500K. Low float.
$Knightscope (KSCP.US)$ Achieves Full Federal Risk and Authorization Management Program (FedRAMP®) Authorization, Unlocking Federal Growth.
$Comstock Inc (LODE.US)$ PR 2/4 Approved for $152 Million Allocation for Oklahoma Qualified Private Activity Bonds
$MAIA Biotechnology (MAIA.US)$ PR 2/4 Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer. Showed median overall survival of 16.9 months compared to 56 months in similar setting.
$Nexalin Technology (NXL.US)$ PR 2/3 Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study. Low float. COH $3.4M good for 10.7 months
$Safety Shot (SHOT.US)$ PR 2/3 announced the termination of its at-the-market (ATM) equity offering program, citing strong financial position and positive outlook.
$Safe Pro Group (SPAI.US)$ PR 1/30 Enters Multi-Year Agreement for its Patented Drone AI Demining Platform with Ukraine's Leading Grain Export and Agricultural Organization. COH $900K good for 2.8 months
$Unusual Machines (UMAC.US)$ PR 2/3 Enters Into a Definive Agreement to Acquire Drone Software Company Aloft Technologies to Grow the American Drone Ecosystem. Low float. COH $3M good for 9.9 months
$Valneva (VALN.US)$ PR 1/30 Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million - Department of Defense (DoD) for the supply of its Japanese encephalitis (JE) vaccine, IXIARO®. No dilution risk.
$Vanda Pharmaceuticals (VNDA.US)$ PR 2/3 Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab for Generalized Pustular Psoriasis. COH $369.7M
$Wearable Devices (WLDS.US)$ PR 2/3 announced the development of Large MUAP Models (LMM), a groundbreaking advancement in AI-powered neural gesture control technology. LMMs aim to decode Motor Unit Action Potentials (MUAPs), the body's muscle communication signals, to enable personalized and intuitive device interactions. COH $6.4M good for 10 months
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE MOMENTUM PLAY
$Digital Turbine (APPS.US)$
$Blue Hat Interactive Entertainment Technology (BHAT.US)$
$COMPASS Pathways (CMPS.US)$
$DHI Group (DHX.US)$
$Huachen AI Parking Management Technology (HCAI.US)$
$Invivyd (IVVD.US)$
$Kirkland's (KIRK.US)$
$Lakeside Holding (LSH.US)$
$MGO Global (MGOL.US)$
$PicoCELA (PCLA.US)$
$Quantum BioPharma (QNTM.US)$
$Transcode Therapeutics (RNAZ.US)$
$SharpLink Gaming (SBET.US)$
$Universe Pharmaceuticals (UPC.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
FORM 4s, 13Gs, 13Ds
$AIM ImmunoTech (AIM.US)$ 1/21 Form 4 Code P Insider buy. COH $2.6M good for 2.1 months
$Ardelyx (ARDX.US)$ 1/22 Form 4 insider buy
$Assembly Biosciences (ASMB.US)$ 12/31 Form 4 insider buying. Low float
$Chijet Motor (CJET.US)$ 1/21 13G 8.72%.
$PMGC Holdings (ELAB.US)$ 1/31 13G 9.6%. Low float.
$KALA BIO (KALA.US)$ 12/31 Form 4 huge insider buying. Low float.
$NAYA Biosciences (NAYA.US)$ 1/16 16 13Gs 9.99% and 6.9%. Low float.
$Outlook Therapeutics (OTLK.US)$ 1/22 13D/A 38.6% ownership up from 25%
$SuperCom (SPCB.US)$ 1/31 13G 7.8%. Low float.
$SaverOne 2014 (SVRE.US)$ 2/5 13G 4.99%.
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
POSSIBLE POST RS SPIKE
$Eyenovia (EYEN.US)$
$Bionano Genomics (BNGO.US)$
$Kaixin Holdings (KXIN.US)$
$Wheeler Real Estate Investment Trust (WHLR.US)$
▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️▪️
STOCK EDUCATION
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
74537207 : thank you very much
, I am starting to miss your 'mega' picks a bit 
7k最后剩多少 : ICON firmly believes it will rebound.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Jaguar8 OP 74537207 : I try to avoid having people focus on the mega picks so they will try to use charts and indicators
Sam19999 : Silent stalker here! Thanks, been learning a lot from you :)
MilaDing : thanks
MilaDing : Just read your article about dark pools, please advise: According to your analysis in the article, do dark pool trades mostly cause prices to fall?
cocobaby : Thank you kind Sir, i hope all is well.
Jaguar8 OP MilaDing : check the stock education I included it there
MilaDing Jaguar8 OP : Yes, I have read it, but I still feel confused. Can you elaborate on under what circumstances the price will fall? So, I don't understand if most dark pool trades will cause stocks to fall or if it varies depending on the buying and selling situation.
Jaguar8 OP MilaDing : i think you need to observe as each stock has different dark pool behavior
View more comments...